Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)he xyl]amino}-1-hydroxyethyl)-8-hydroxyqu inolin-2(1H)-one as agonist of the beta 2 adrenergic receptor

Details for Australian Patent Application No. 2008213109 (hide)

Owner Almirall, S.A.

Inventors Puig Duran, Carlos; Moyes Valls, Enrique

Agent Davies Collison Cave

Pub. Number AU-A-2008213109

PCT Pub. Number WO2008/095720

Priority P200700362 09.02.07 ES

Filing date 8 February 2008

Wipo publication date 14 August 2008

International Classifications

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/095720 Priority application(s): WO2008/095720

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008213143-Fishing reel

2008213095-Security element